US EditionDr Lal PathLabs adds Illumina’s NovaSeq X to its genomics division
Summary by Express Healthcare
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Dr Lal PathLabs adds Illumina’s NovaSeq X to its genomics division
Dr. Lal PathLabs has expanded its genomics capabilities by adding Illumina’s NovaSeq X Series to its dedicated genomics division, Genevolve. With the integration of Illumina’s latest technology, DLPL can now deliver faster and more accurate genomic research insights. The NovaSeq X system, featuring Illumina’s XLEAP-SBS chemistry, can generate more than 20,000 whole genomes per year, more than double the throughput of Illumina’s previous sequenc…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
